These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 19489875)
1. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875 [TBL] [Abstract][Full Text] [Related]
2. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292 [TBL] [Abstract][Full Text] [Related]
3. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence. Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299 [TBL] [Abstract][Full Text] [Related]
4. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease). Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019 [TBL] [Abstract][Full Text] [Related]
5. Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Wisniewski KE; Zhong N; Kaczmarski W; Kaczmarski A; Kida E; Brown WT; Schwarz KO; Lazzarini AM; Rubin AJ; Stenroos ES; Johnson WG; Wisniewski TM Ann Neurol; 1998 Jan; 43(1):106-10. PubMed ID: 9450775 [TBL] [Abstract][Full Text] [Related]
6. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis. Drack AV; Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479 [TBL] [Abstract][Full Text] [Related]
7. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
8. Defective lysosomal arginine transport in juvenile Batten disease. Ramirez-Montealegre D; Pearce DA Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196 [TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in the eye of a mouse model for batten disease. Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100 [TBL] [Abstract][Full Text] [Related]
10. A novel in-frame mutation in Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110 [No Abstract] [Full Text] [Related]
11. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course. Aberg L; Lauronen L; Hämäläinen J; Mole SE; Autti T Pediatr Neurol; 2009 Feb; 40(2):134-7. PubMed ID: 19135632 [TBL] [Abstract][Full Text] [Related]
13. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110 [TBL] [Abstract][Full Text] [Related]
14. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Pineda-Trujillo N; Cornejo W; Carrizosa J; Wheeler RB; Múnera S; Valencia A; Agudelo-Arango J; Cogollo A; Anderson G; Bedoya G; Mole SE; Ruíz-Linares A Neurology; 2005 Feb; 64(4):740-2. PubMed ID: 15728307 [TBL] [Abstract][Full Text] [Related]
15. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models. Chan CH; Mitchison HM; Pearce DA Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598 [TBL] [Abstract][Full Text] [Related]
16. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis. Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292 [TBL] [Abstract][Full Text] [Related]
17. Full-field ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene. Eksandh LB; Ponjavic VB; Munroe PB; Eiberg HE; Uvebrant PE; Ehinger BE; Mole SE; Andréasson S Ophthalmic Genet; 2000 Jun; 21(2):69-77. PubMed ID: 10916181 [TBL] [Abstract][Full Text] [Related]
18. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis. Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy. Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874 [TBL] [Abstract][Full Text] [Related]
20. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. Xiong J; Kielian T J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]